2018 annual financial data
BridgeBio Pharma 2018 Net margin
BridgeBio Pharma 2018 net margin with verified reported values.
Direct answer
Net margin was Not calculable.
Operating income was -183,660,000 USD and net income was -130,749,000 USD.
Operating cash flow was -136,643,000 USD.
Get free BridgeBio Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -183,660,000 USD
- Net income
- -130,749,000 USD
- Operating cash flow
- -136,643,000 USD